This Week's Herman Trend Alert

Leadership in Normal 2.0

  The Herman Trend Alert

August 6, 2014

Diabetes Breakthrough on the Way

According the Juvenile Diabetes Research Foundation, "Type 1 Diabetes (T1D) is an autoimmune disease in which a person's pancreas stops producing insulin, [the] hormone that enables people to get energy from food. It occurs when the body's immune system attacks and destroys the insulin-producing cells in the pancreas. Its onset has nothing to do with diet or lifestyle." Up to this time, there has been nothing anyone could do to prevent T1D, and nothing anyone could do to get rid of it.

To give you a sense for the magnitude of this disease, in the United States alone, approximately 80 people per day are diagnosed with T1D. That's 15,000 adults and 15,000 children every year who are diagnosed. And unfortunately, the numbers are growing--- worldwide the incidence among children under age 14 is estimated to increase by three percent every year. Across the globe, the costs are in the trillions.

Flying under the radar is a promising breakthrough in T1D treatment---and perhaps reversal of T1D altogether. A brilliant researcher Dr. Denise Faustman at the Massachusetts General Hospital Immunobiology Lab is conducting research to develop a curative therapy for T1D.

This promising program is investigating whether bacillus Calmette-Guerin (BCG) vaccination will eliminate the pancreas-destroying T cells in humans with advanced T1D. BCG is a generic drug that has been used for over 80 years in different vaccination capacities, including in the treatment of tuberculosis. In humans, BCG temporarily elevates levels of a substance called tumor necrosis factor (TNF). A Phase I human clinical trial has demonstrated that elevating TNF can eliminate the bad T cells in the blood of individuals with type T1D, which is showing promising clinical benefits. The researchers are currently testing BCG at different doses and schedules than those that had been used in the past to treat other diseases.

This application of BCG holds great promise for an effective diabetes treatment. This breakthrough represents a major milestone in the effective treatment of autoimmune diseases, which are affecting growing numbers of people across the globe. Perhaps the use of BCG will be a model for the treatment of other autoimmune disease, like Fibromyalgia, Lupus, and Myositis.

For more information or to donate to this important research, visit their website at or call 617-726-4084.

© Copyright 1998- by The Herman Group, Inc. -- reproduction for publication is encouraged, with the following attribution: From "The Herman Trend Alert," by Joyce Gioia, Strategic Business Futurist. 336-210-3548 or To sign up, visit The Herman Trend Alert is a trademark of The Herman Group, Inc."

Our author Joyce gets quoted in TIME Magazine and other national media on a regular basis. You can, too! Sign up for You will be found by the news media and in Google search: 1. Through your personal search-engine-optimized press room by 39 topics you choose; 2. By news releases pushed out 10 ways including Google News; 3. Be found in the 2020 printed Yearbook of Experts, Authorities & Spokespersons. Save 15% when you register by October 31st @

The Association of Professional Futurists proudly presents its annual online learning experiences on Full Spectrum Futures. Network with leading futurists from all over the world. And best of all, it's free to attend, though contributions are encouraged to help defray costs. For more information, visit here.

Excellent translation services from English, French, or German into Spanish. Especially well-versed in medicine/pharma and automobile industries. 5-year Bachelor Degree in Translation. Also editing and proofreading of all kinds of Spanish language documents. Flexible rates, depending on number of words, degree of difficulty/technicality, and turnaround. For an instant quote email Mariana Campora Lesti at or contact her on SKYPE at marianacampora.

To read this Herman Trend Alert on the web:

Herman Trend Alerts are produced by the Herman Group, strategic business futurists, Certified Management Consultants, authors, and professional speakers.

New subscribers are always welcome. There is no charge for this public service. The Herman Trend Alert is read by over 30,000 people in 90 countries, including other websites and printed periodicals. Click here to sign up for the Herman Trend Alert.

Do you enjoy receiving this weekly e-mail update? Contact us about our co-branded Herman Trend Alert service.

Subscribe or Unsubscribe to weekly Herman Trend Alert
View this week's Herman Trend Alert
Archived Weekly Herman Trend Alerts


[ Home About Products Resources Media ]


7112 Viridian Lane
Austin, TX 78739
Voice: 336-210-3548
Toll Free in US & Canada: 800-227-3566

  © The Herman Group. All rights reserved.

Web site design by WebEditor Design Services, Inc.